{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:33:01Z","timestamp":1793694781961,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004386","name":"University of Malaya","doi-asserted-by":"publisher","award":["RG309-14AFR"],"award-info":[{"award-number":["RG309-14AFR"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004386","name":"University of Malaya","doi-asserted-by":"publisher","award":["BK043-2014"],"award-info":[{"award-number":["BK043-2014"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.antiviral.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T07:00:50Z","timestamp":1453100450000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in\u00a0vitro and in\u00a0vivo"],"prefix":"10.1016","volume":"127","author":[{"given":"Hussin A.","family":"Rothan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirbod","family":"Bahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar Y.","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulqarnain","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teow Chong","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatrah","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurshamimi Nor","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorsaadah A.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohana","family":"Yusof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.01.006_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.TP.0000149499.78996.B3","article-title":"Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C","volume":"79","author":"Bizollon","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2016.01.006_bib2","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0140-6736(07)61752-8","article-title":"Chikungunya in Europe: what's next?","volume":"370","author":"Chretien","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.01.006_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/590970","article-title":"Antiviral activity of cidofovir and ribavirin against the new human adenovirus subtype 14a that is associated with severe pneumonia","volume":"47","author":"Darr","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.01.006_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/135965350501000710","article-title":"Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy","volume":"10","author":"Fuster","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.01.006_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2334-8-99","article-title":"Estimating Chikungunya prevalence in La Reunion Island outbreak by serosurveys: two methods for two critical times of the epidemic","volume":"8","author":"Gerardin","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.01.006_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/0022-1317-4-2-203","article-title":"Comparison of the antiviral activity in vitro of some nonsteroidal anti-inflammatory drugs","volume":"4","author":"Inglot","year":"1969","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.01.006_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2008.01.043","article-title":"In\u00a0vivo antiviral activity of ribavirin\/alpha-cyclodextrin complex: evaluation on experimental measles virus encephalitis in mice","volume":"357","author":"Jeulin","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.antiviral.2016.01.006_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/emmm.201200213","article-title":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","volume":"4","author":"Kam","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.antiviral.2016.01.006_bib32","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2016.01.006_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2008.03.027","article-title":"Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients","volume":"49","author":"Lawitz","year":"2008","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2016.01.006_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0035-9203(57)90022-6","article-title":"An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952\u201353; an additional note on Chikungunya virus isolations and serum antibodies","volume":"51","author":"Mason","year":"1957","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.01.006_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","article-title":"A\u00a0mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence","volume":"178","author":"Morrison","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2016.01.006_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.str.2005.07.025","article-title":"Mapping the structure and function of the E1 and E2 glycoproteins in alphaviruses","volume":"14","author":"Mukhopadhyay","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2016.01.006_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/jtbi.1995.0146","article-title":"Immune responses against multiple epitopes","volume":"175","author":"Nowak","year":"1995","journal-title":"J.\u00a0Theor. Biol."},{"issue":"6","key":"10.1016\/j.antiviral.2016.01.006_bib14","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1371\/journal.pone.0000527","article-title":"Human muscle satellite cells as targets of chikungunya virus infection","volume":"2","author":"Ozden","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.01.006_bib15","doi-asserted-by":"crossref","first-page":"e2405","DOI":"10.1371\/journal.pntd.0002405","article-title":"Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in\u00a0vitro and protects mice infected with the virus","volume":"7","author":"Parashar","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.01.006_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(07)70107-X","article-title":"Chikungunya, an epidemic arbovirosis","volume":"7","author":"Pialoux","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.01.006_bib17","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1128\/JVI.75.21.10118-10131.2001","article-title":"Evolutionary relationships and systematics of the alphaviruses","volume":"75","author":"Powers","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.01.006_bib18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/jm400460d","article-title":"Chikungunya virus: emerging targets and new opportunities for medicinal chemistry","volume":"57","author":"Rashad","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.01.006_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1473-3099(06)70531-X","article-title":"Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem?","volume":"6","author":"Reiter","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.01.006_bib20","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(07)61779-6","article-title":"Infection with chikungunya virus in Italy: an outbreak in a temperate region","volume":"370","author":"Rezza","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.antiviral.2016.01.006_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro2368","article-title":"Biology and pathogenesis of chikungunya virus","volume":"8","author":"Schwartz","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2016.01.006_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1472-765X.2012.03282.x","article-title":"Combination of N-methylisatin-beta-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in\u00a0vitro","volume":"55","author":"Sebastian","year":"2012","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.antiviral.2016.01.006_bib22","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1371\/journal.ppat.0030089","article-title":"Characterization of reemerging chikungunya virus","volume":"3","author":"Sourisseau","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.01.006_bib23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/605496","article-title":"Chikungunya fever: an epidemiological review of a re-emerging infectious disease","volume":"49","author":"Staples","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.01.006_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2016.01.006_bib25","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.ppat.0030201","article-title":"A\u00a0single mutation in chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Tsetsarkin","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.01.006_bib26","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1128\/JVI.03213-14","article-title":"Mutations conferring a noncytotoxic phenotype on Chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2","volume":"89","author":"Utt","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.01.006_bib27","doi-asserted-by":"crossref","first-page":"e1168","DOI":"10.1371\/journal.pone.0001168","article-title":"Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus","volume":"2","author":"Vazeille","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.01.006_bib29","unstructured":"WHO (2015), Pan American Health Organisation, http:\/\/www.paho.org\/hq\/?Itemid=40931."},{"issue":"1","key":"10.1016\/j.antiviral.2016.01.006_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virol.2012.07.018","article-title":"Factors affecting herpes simplex virus reactivation from the explanted mouse brain","volume":"433","author":"Yao","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.01.006_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2008.79.133","article-title":"An animal model for studying the pathogenesis of chikungunya virus infection","volume":"79","author":"Ziegler","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T21:10:57Z","timestamp":1654117857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216300080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":32,"alternative-id":["S0166354216300080"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.01.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in\u00a0vitro and in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}